vs
Side-by-side financial comparison of Fold Holdings, Inc. (FLD) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
ROCKWELL MEDICAL, INC. is the larger business by last-quarter revenue ($17.3M vs $9.1M, roughly 1.9× Fold Holdings, Inc.). ROCKWELL MEDICAL, INC. runs the higher net margin — -9.2% vs -379.9%, a 370.7% gap on every dollar of revenue. On growth, Fold Holdings, Inc. posted the faster year-over-year revenue change (8.2% vs -8.5%). Over the past eight quarters, Fold Holdings, Inc.'s revenue compounded faster (36.1% CAGR vs -18.2%).
Fold Holdings, Inc. is a U.S.-based fintech firm specializing in crypto-integrated consumer financial products. Its core offerings include a rewards debit card that provides Bitcoin and other cryptocurrency cashback on routine purchases, alongside user-friendly digital wallet tools for secure crypto storage, serving primarily the North American consumer market.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
FLD vs RMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $9.1M | $17.3M |
| Net Profit | $-34.7M | $-1.6M |
| Gross Margin | — | 16.8% |
| Operating Margin | -380.0% | — |
| Net Margin | -379.9% | -9.2% |
| Revenue YoY | 8.2% | -8.5% |
| Net Profit YoY | -7232.4% | — |
| EPS (diluted) | $-0.02 | $-0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $17.3M | ||
| Q4 25 | $9.1M | $18.3M | ||
| Q3 25 | $7.4M | $15.9M | ||
| Q2 25 | $8.2M | $16.1M | ||
| Q1 25 | $7.1M | $18.9M | ||
| Q4 24 | $8.4M | $24.7M | ||
| Q3 24 | $5.2M | $28.3M | ||
| Q2 24 | $5.1M | $25.8M |
| Q1 26 | — | $-1.6M | ||
| Q4 25 | $-34.7M | $-554.0K | ||
| Q3 25 | $554.2K | $-1.8M | ||
| Q2 25 | $13.4M | $-1.5M | ||
| Q1 25 | $-48.9M | $-1.5M | ||
| Q4 24 | $486.4K | $-756.0K | ||
| Q3 24 | $-62.3M | $1.7M | ||
| Q2 24 | $-2.3M | $343.0K |
| Q1 26 | — | 16.8% | ||
| Q4 25 | — | 21.1% | ||
| Q3 25 | — | 14.3% | ||
| Q2 25 | — | 15.6% | ||
| Q1 25 | — | 16.1% | ||
| Q4 24 | — | 14.7% | ||
| Q3 24 | — | 22.0% | ||
| Q2 24 | — | 17.6% |
| Q1 26 | — | — | ||
| Q4 25 | -380.0% | -2.2% | ||
| Q3 25 | 7.5% | -9.9% | ||
| Q2 25 | — | -8.4% | ||
| Q1 25 | -689.6% | -7.2% | ||
| Q4 24 | -9.1% | -2.1% | ||
| Q3 24 | -15.3% | 6.8% | ||
| Q2 24 | -12.2% | 2.0% |
| Q1 26 | — | -9.2% | ||
| Q4 25 | -379.9% | -3.0% | ||
| Q3 25 | 7.5% | -11.0% | ||
| Q2 25 | 164.2% | -9.3% | ||
| Q1 25 | -689.6% | -8.0% | ||
| Q4 24 | 5.8% | -3.1% | ||
| Q3 24 | -1188.7% | 5.9% | ||
| Q2 24 | -45.1% | 1.3% |
| Q1 26 | — | $-0.04 | ||
| Q4 25 | $-0.02 | $-0.01 | ||
| Q3 25 | $0.01 | $-0.05 | ||
| Q2 25 | $0.28 | $-0.05 | ||
| Q1 25 | $-1.92 | $-0.04 | ||
| Q4 24 | $0.09 | $-0.02 | ||
| Q3 24 | $-10.68 | $0.04 | ||
| Q2 24 | $-0.40 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $7.7M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $63.0M | $35.9M |
| Total Assets | $153.5M | $57.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $7.7M | $10.7M | ||
| Q3 25 | $6.7M | $13.6M | ||
| Q2 25 | $6.6M | $12.5M | ||
| Q1 25 | $11.7M | $11.4M | ||
| Q4 24 | $18.3M | $15.7M | ||
| Q3 24 | — | $12.3M | ||
| Q2 24 | — | $11.9M |
| Q1 26 | — | $35.9M | ||
| Q4 25 | $63.0M | $37.0M | ||
| Q3 25 | $94.7M | $37.0M | ||
| Q2 25 | $88.5M | $30.4M | ||
| Q1 25 | $71.9M | $31.5M | ||
| Q4 24 | $-67.8M | $32.6M | ||
| Q3 24 | $-7.4M | $29.1M | ||
| Q2 24 | $-74.0M | $23.5M |
| Q1 26 | — | $57.4M | ||
| Q4 25 | $153.5M | $57.1M | ||
| Q3 25 | $191.0M | $57.5M | ||
| Q2 25 | $182.1M | $52.6M | ||
| Q1 25 | $148.5M | $54.0M | ||
| Q4 24 | $125.7M | $59.2M | ||
| Q3 24 | $52.2M | $57.1M | ||
| Q2 24 | $51.8M | $53.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-16.1M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-16.1M | $2.3M | ||
| Q3 25 | $-2.5M | $-1.3M | ||
| Q2 25 | $-4.0M | $1.8M | ||
| Q1 25 | $-5.0M | $-3.5M | ||
| Q4 24 | $-3.3M | $865.0K | ||
| Q3 24 | $-2.2M | $4.3M | ||
| Q2 24 | $-859.6K | $1.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | $2.2M | ||
| Q3 25 | — | $-1.5M | ||
| Q2 25 | — | $1.7M | ||
| Q1 25 | — | $-3.5M | ||
| Q4 24 | — | $470.0K | ||
| Q3 24 | — | $4.1M | ||
| Q2 24 | — | $1.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | 12.0% | ||
| Q3 25 | — | -9.6% | ||
| Q2 25 | — | 10.5% | ||
| Q1 25 | — | -18.8% | ||
| Q4 24 | — | 1.9% | ||
| Q3 24 | — | 14.4% | ||
| Q2 24 | — | 4.5% |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.5% | ||
| Q3 25 | — | 1.4% | ||
| Q2 25 | — | 1.0% | ||
| Q1 25 | — | 0.3% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 0.7% | ||
| Q2 24 | — | 1.1% |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | -4.47× | — | ||
| Q2 25 | -0.30× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -6.82× | — | ||
| Q3 24 | — | 2.57× | ||
| Q2 24 | — | 4.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FLD
| Banking And Payment Revenues | $8.4M | 92% |
| Other | $706.0K | 8% |
RMTI
Segment breakdown not available.
